Literature DB >> 30530899

Can Grail find the trail to early cancer detection?

Clare Fiala1, Eleftherios P Diamandis1,2,3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30530899     DOI： 10.1515/cclm-2018-1249

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN： 1434-6621            Impact factor:   3.694


× No keyword cloud information.
  3 in total

Review 1.  Next-Generation Sequencing on Circulating Tumor DNA in Advanced Solid Cancer: Swiss Army Knife for the Molecular Tumor Board? A Review of the Literature Focused on FDA Approved Test.

Authors:  Damien Vasseur; Hela Sassi; Arnaud Bayle; Marco Tagliamento; Benjamin Besse; Christophe Marzac; Ahmadreza Arbab; Nathalie Auger; Sophie Cotteret; Mihaela Aldea; Félix Blanc-Durand; Arthur Géraud; Anas Gazzah; Yohann Loriot; Antoine Hollebecque; Patricia Martín-Romano; Maud Ngo-Camus; Claudio Nicotra; Santiago Ponce; Madona Sakkal; Olivier Caron; Cristina Smolenschi; Jean-Baptiste Micol; Antoine Italiano; Etienne Rouleau; Ludovic Lacroix
Journal:  Cells       Date:  2022-06-11       Impact factor: 7.666

2.  Multi Cancer Early Detection by Using Circulating Tumor DNA-The Galleri Test. Reply to Klein et al. The Promise of Multicancer Early Detection. Comment on "Pons-Belda et al. Can Circulating Tumor DNA Support a Successful Screening Test for Early Cancer Detection? The Grail Paradigm. Diagnostics 2021, 11, 2171".

Authors:  Oscar D Pons-Belda; Amaia Fernandez-Uriarte; Eleftherios P Diamandis
Journal:  Diagnostics (Basel)       Date:  2022-05-17

3.  Can Circulating Tumor DNA Support a Successful Screening Test for Early Cancer Detection? The Grail Paradigm.

Authors:  Oscar D Pons-Belda; Amaia Fernandez-Uriarte; Eleftherios P Diamandis
Journal:  Diagnostics (Basel)       Date:  2021-11-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.